You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 143 No. 7, July 1983 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL INVESTIGATIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (51)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

The Clinical Course of End-Stage Renal Disease in Systemic Lupus Erythematosus

Mark P. Jarrett, MD; Subramanyan Santhanam, MD; Francesco Del Greco, MD

Arch Intern Med. 1983;143(7):1353-1356.


Abstract



• Despite treatment advances, renal failure still develops in patients with systemic lupus erythematosus (SLE). With the common use of long-term maintenance hemodialysis, this complication is no longer fatal. In order to evaluate factors that contribute to the outcome of patients with SLE receiving long-term hemodialysis, we retrospectively analyzed the clinical course of 14 patients with SLE receiving hemodialysis for more than three months, and compared them with 62 patients receiving long-term hemodialysis who did not have SLE. While receiving long-term hemodialysis, SLE activity was minimal, with most manifestations involving the CNS or synovitis. Five-year survival was significantly lower in the SLE than in the non-SLE group (58.6% v 88.5%), but no deaths were directly attributable to SLE activity. Morbidity in the SLE group was primarily due to infection and vascular access problems.

(Arch Intern Med 1983;143:1353-1356)



Author Affiliations



From the Department of Medicine, Sections of Arthritis and Connective Tissue Disease (Dr Jarrett) and Nephrology (Drs Santhanam and Del Greco), Northwestern University Medical School, Chicago. Dr Jarrett is currently with the Department of Medicine, Division of Rheumatology, State University of New York Downstate Medical Center.


Footnotes



Accepted for publication March 1, 1983.

Reprint requests to Northwestern University Medical School, 303 E Chicago Ave, Chicago, IL 60611 (Dr Santhanam).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Recurrence of Lupus Nephritis after Kidney Transplantation
Contreras et al.
J. Am. Soc. Nephrol. 2010;21:1200-1207.
ABSTRACT | FULL TEXT  

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics
Bertsias et al.
Ann Rheum Dis 2008;67:195-205.
ABSTRACT | FULL TEXT  

Poor prognosis of end-stage renal disease in systemic lupus erythematosus: a cohort of Chinese patients
Lee et al.
Lupus 2003;12:827-832.
ABSTRACT  

Unusual lung consolidation in SLE
Nomura et al.
Thorax 2003;58:367-367.
FULL TEXT  

Systemic Lupus Erythematosus after Renal Transplantation: Patient and Graft Survival and Disease Activity
Nossent et al.
ANN INTERN MED 1991;114:183-188.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.